http://www.gurufocus.com/news/995213/bayer-and-teva-double-down-on-worst-ma-deals-of-decade
Dec 04, 2019 - Bayer and Teva Double Down on Worst M&A Deals of Decade, Stocks: BAYN,TEVA,GILD,MRK,NVS,BMY,PFE,GSK,SHRS,SNY,AMGN,A, release date:Dec 03, 2019
0
gf:8609422960018291878
0
http://www.zacks.com/stock/news/653885/jjs-jnj-new-tests-reveal-no-asbestos-in-baby-powders?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-653885
Dec 04, 2019 - J&J (JNJ) says that two third-party labs conducted 155 tests on samples of its baby powders. All these tests confirm that the talc does not contain asbestos, a known carcinogen.
zc:3525489596121836971
0
https://seekingalpha.com/article/4309342-bear-attack-teva-pharmaceutical-must-end?source=feed_tag_israel
Nov 26, 2019 - Renewed bearishness on Teva over the opioid subpoena may prove short-lived.Third-quarter results a positive inflection point.Business recovery underway.
0
sa:-5958568801809856735
0
https://seekingalpha.com/article/4309342-why-bear-attack-on-teva-pharmaceutical-must-end?source=feed_tag_israel
Nov 26, 2019 - Renewed bearishness on Teva over the opioid subpoena may prove short-lived.Third-quarter results a positive inflection point.Business recovery underway.
0
sa:5403012244099823373
0
http://www.zacks.com/stock/news/641354/generic-drugmakers-gain-as-price-fixing-probe-nears-an-end?cid=CS-ZC-FT-analyst_blog|investment_ideas-641354
Nov 26, 2019 - Shares of generic drugmakers rose on Monday on a possible end to the persistent price-fixing probe.
zc:7178835359926298786
0
https://seekingalpha.com/news/3521819-teva-talks-doj-end-generics-probe-bloomberg?source=feed_news_all
Nov 25, 2019 - Teva Pharmaceuticals (TEVA +6.5%) pops higher in morning trade following a Bloomberg report that it has held talks with the U.S. Department of Justice about resolving a criminal antitrust probe of all
0
sa:2741540286449930204
0
https://seekingalpha.com/news/3521812-teva-inks-early-stage-drug-research-deals?source=feed_news_all
Nov 25, 2019 - Teva (NYSE:TEVA) is starting the week up 5.6% after signing research agreements with two leading Israeli academic institutes to boost its early-stage drug development.A partnership with Tel Aviv Unive
0
sa:744742026467327297
0
http://www.zacks.com/stock/news/631469/endos-endp-bla-for-cellulite-treatment-accepted-by-fda?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-631469
Nov 21, 2019 - The FDA accepts Endo's (ENDP) BLA for CCH for the treatment of cellulite in the buttocks.
zc:-214309546673181699
0
https://seekingalpha.com/article/4308148-teva-due-substantial-re-rating?source=feed_tag_israel
Nov 20, 2019 - Thanks to its debt offering, a heavily dilutive equity issuance has become very unlikely.The upsized offering also highlights that debt markets are not seeing a large bankruptcy risk.The only remainin
0
sa:-6825145865901867608
0
https://seekingalpha.com/article/4308148-teva-is-due-for-substantial-re-rating?source=feed_tag_israel
Nov 20, 2019 -
0
sa:7970774651038376192
0